Cite
HARVARD Citation
Jahnmatz, M. et al. (2020). Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study. Lancet infectious diseases. 20 (11), pp. 1290-1301. [Online].